WallStreetZenWallStreetZen

NASDAQ: HQY
Healthequity Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HQY past earnings growth

How has HQY's earnings growth performed historically?
Company
713.33%
Industry
35.26%
Market
53.53%
HQY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HQY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HQY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HQY past revenue growth

How has HQY's revenue growth performed historically?
Company
17.19%
Industry
9.41%
Market
16.91%
HQY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HQY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HQY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HQY earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$105.7M
Current Profit Margin
9.6%

HQY Return on Equity

Current Company
5.1%
Current Industry
6.1%
Current Market
33.8%
HQY's Return on Equity (5.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HQY announces earnings.

HQY Return on Assets

Current Company
3.2%
Current Industry
2.3%
HQY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HQY Return on Capital Employed

Current Company
5.45%
Current Industry
5.6%
HQY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HQY vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HQY$1.10B$343.31M$105.67M+28.00%-3.26%
DOCS$493.63M$216.09M$160.55M+100.99%+113.37%
RCM$1.75B$443.00M-$40.00M+10.07%N/A
WAY$863.29M$290.15M-$73.52M+15.55%N/A
EVH$2.35B$71.31M-$106.20M+26.29%N/A
View Top Health Information Service Stocks

Healthequity Earnings & Revenue FAQ

What were HQY's earnings last quarter?

On Invalid Date, Healthequity (NASDAQ: HQY) reported Q2 2024 earnings per share (EPS) of $0.41, up 241.67% year over year. Total Healthequity earnings for the quarter were $35.82 million. In the same quarter last year, Healthequity's earnings per share (EPS) was $0.12.

If you're new to stock investing, here's how to buy Healthequity stock.

What was HQY's earnings growth in the past year?

As of Q3 2024, Healthequity's earnings has grown 713.33% year over year. This is 678.07 percentage points higher than the US Health Information Services industry earnings growth rate of 35.26%. Healthequity's earnings in the past year totalled $105.67 million.

What was HQY's revenue last quarter?

On Invalid Date, Healthequity (NASDAQ: HQY) reported Q2 2024 revenue of $299.93 million up 23.15% year over year. In the same quarter last year, Healthequity's revenue was $243.55 million.

What was HQY's revenue growth in the past year?

As of Q3 2024, Healthequity's revenue has grown 17.19% year over year. This is 7.78 percentage points higher than the US Health Information Services industry revenue growth rate of 9.41%. Healthequity's revenue in the past year totalled $1.10 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.